Alcedo, JavierSerra, JordiPérez de la Serna, JulioMas, PilarBarba, ElizabethSuárez, José FranciscoAccarino, Annaen representación de la Asociación Española de Neurogastroenterología y Motilidad (ASENEM)2023-02-092023-02-092020-06-18http://hdl.handle.net/10668/15956The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was responsible for the outbreak of the 2019 coronavirus disease (COVID-19), which is now considered as a pandemic. The prevention strategies adopted have included social distancing measures and the modification, reduction or interruption of a large proportion of routine healthcare activity. This has had a significant impact on the care provided in Gastrointestinal Motility Units. Having passed the peak, in terms of mortality and infections, a gradual reduction in transmission figures has been observed in Spain and other European countries. The risk of reactivation, however, remains high, so it is necessary to have a plan in place that allows healthcare centres to safely resume, for their patients and professionals, instrumental examinations linked to the management of motor pathology. Based on the available scientific evidence and the consensus of a panel of experts, the Spanish Association of Neurogastroenterology and Motility (ASENEM) has drawn up a series of practical recommendations, which have been adapted to the risks inherent in each activity. These include individual protection proposals, as well as organisational and structural measures, which are conceived to allow for the gradual resumption of examinations while minimising the possibility of contagion.enBreath-testCOVID-19 pandemicDesinfecciónDesinfectionDigestive motility disordersEPIManometryManometríaPCRPPEPandemia COVID-19Reinicio de actividadResumption of activitySARS-CoV-2Test de alientoTrastornos de la motilidad digestivapH-impedancepH-impedanciaBetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesContinuity of Patient CareCoronavirus InfectionsEvidence-Based MedicineGastrointestinal MotilityHealth Facility ClosureHumansInfection ControlLaboratoriesPandemicsPatient IsolationPneumonia, ViralRisk AssessmentRisk ManagementSARS-CoV-2Spainresearch article32680731open access10.1016/j.gastrohep.2020.05.0110210-5705PMC7301085https://doi.org/10.1016/j.gastrohep.2020.05.011https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301085/pdf